A new framework of spatial targeting for single-species conservation planning

Context

Organisations acting to conserve and protect species across large spatial scales prioritise to optimise use of resources. Spatial conservation prioritization tools typically focus on identifying areas containing species groups of interest, with few tools used to identify the best areas for single-species conservation, in particular, to conserve currently widespread but declining species.

Objective

A single-species prioritization framework, based on temporal and spatial patterns of occupancy and abundance, was developed to spatially prioritize conservation action for widespread species by identifying smaller areas to work within to achieve predefined conservation objectives.

Methods

We demonstrate our approach for 29 widespread bird species in the UK, using breeding bird atlas data from two periods to define distribution, relative abundance and change in relative abundance. We selected occupied 10-km squares with abundance trends that matched species conservation objectives relating to maintaining or increasing population size or range, and then identified spatial clusters of squares for each objective using a Getis-Ord-Gi* or near neighbour analysis.

Results

For each species, the framework identified clusters of 20-km squares that enabled us to identify small areas in which species recovery action could be prioritized.

Conclusions

Our approach identified a proportion of species’ ranges to prioritize for species recovery. This approach is a relatively quick process that can be used to inform single-species conservation for any taxa if sufficiently fine-scale occupancy and abundance information is available for two or more time periods. This is a relatively simple first step for planning single-species focussed conservation to help optimise resource use.

     

Primary bronchotomy for removal of an intrabronchial foreign body in a dog.

An 8-year-old, spayed female toy poodle presented with wounds sustained from a dog fight. The multiple orthopedic injuries present were managed surgically. Months later, a chronic cough developed secondary to an aspirated canine tooth in the mainstem bronchus of the right cranial lung that was nonresponsive to medical management. A thoracotomy and primary bronchotomy were performed to remove the aspirated tooth, resulting in complete resolution of clinical signs. Bronchial foreign bodies are rarely diagnosed in companion animals. Primary bronchotomy is an alternative to bronchoscopy or lung lobectomy in cases that do not respond to medical management.     

Plant-pathogenic bacteria as biological weapons - real threats?

At present, much attention is being given to the potential of plant pathogens, including plant-pathogenic bacteria, as biological weapons/bioterror weapons. These two terms are sometimes used interchangeably and there is need for care in their application. It has been claimed that clandestine introduction of certain plant-pathogenic bacteria could cause such crop losses as to impact so significantly on a national economy and thus constitute a threat to national security. As a separate outcome, it is suggested that they could cause serious public alarm, perhaps constituting a source of terror. Legislation is now in place to regulate selected plant-pathogenic bacteria as potential weapons. However, we consider it highly doubtful that any plant-pathogenic bacterium has the requisite capabilities to justify such a classification. Even if they were so capable, the differentiation of pathogens into a special category with regulations that are even more restrictive than those currently applied in quarantine legislation of most jurisdictions offers no obvious benefit. Moreover, we believe that such regulations are disadvantageous insofar as they limit research on precisely those pathogens most in need of study. Whereas some human and animal pathogens may have potential as biological or bioterror weapons, we conclude that it is unlikely that any plant-pathogenic bacterium realistically falls into this category.     

Using distribution models to test alternative hypotheses about a species’ environmental limits and recovery prospects

Distribution models are commonly used to generalise across species distributions, to project future potential range changes, and to identify potential areas for species reintroductions and recovery plans. Building several models that incorporate different potential causal factors is a useful way of formalising alternative hypotheses. We developed a series of models to test hypotheses about the factors influencing the distribution of a species of conservation importance - the hen harrier Circus cyaneus.A climate-based model using continental distribution data was consistent with the continental distribution and observational studies in Britain. According to the climate-model the parts of Britain occupied by the hen harrier are the least climatically suitable.Habitat-based models using detailed distribution data from seven Scottish areas explained the recent British distribution well, with birds largely confined to heather dominated areas. These patterns were inconsistent with historical data on the species’ distribution, its habitat use in other parts of its range and with the climate-based model.Our burn intensity index of gamekeeper activity was highly correlated with climatic suitability within the best 25% of 10 km squares by modelled habitat suitability, negatively associated with the productivity data and associated with a decrease in abundances between 1998 and 2004. Gamekeeper activity may be keeping hen harriers out of the most climatically suitable areas with habitat similar to that which they currently occupy within Britain and or keeping the population numbers too low and isolated for the natural re-expansion of the species into parts of the range where it was historically extirpated.     

Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours

The purpose of this study was to provide an initial assessment of the potential biologic activity of toceranib phosphate (Palladia?, Pfizer Animal Health, Madison, NJ, USA) in select solid tumours in dogs. Cases in which toceranib was used to treat dogs with apocrine gland anal sac adenocarcinoma (AGASACA), metastatic osteosarcoma (OSA), thyroid carcinoma, head and neck carcinoma and nasal carcinoma were included. Clinical benefit (CB) was observed in 63/85 (74%) dogs including 28/32 AGASACA [8 partial response (PR), 20 stable disease (SD)], 11/23 OSAs (1 PR and 10 SD), 12/15 thyroid carcinomas (4 PR and 8 SD), 7/8 head and neck carcinomas [1 complete response (CR), 5 PR and 1 SD] and 5/7 (1 CR and 4 SD) nasal carcinomas. For dogs experiencing CB, the median dose of toceranib was 2.8 mg kg(-1) , 36/63 (58.7%) were dosed on a Monday/Wednesday/Friday basis and 47/63 (74.6%) were treated 4 months or longer. Although these data provide preliminary evidence that toceranib exhibits CB in dogs with certain solid tumours, future prospective studies are necessary to define its true activity.